Literature DB >> 11677743

The contribution of nitric oxide to vestibular compensation: are there species differences?

P F Smith1, Y Zheng, S Paterson, C L Darlington.   

Abstract

Nitric oxide (NO) has been implicated in the processes by which animals recover from peripheral vestibular damage ("vestibular compensation"). However, there is little systematic data available on the effects of NO inhibition on the vestibular compensation process. In the present study we administered the nitric oxide synthase (NOS) inhibitor NG-nitro-L-arginine methyl ester (L-NAME) using a subcutaneous osmotic minipump and examined its effects on the compensation of spontaneous nystagmus (SN), yaw head tilt (YHT) and roll head tilt (RHT) in guinea pigs. Following unilateral labyrinthectomy (UL), treatment with 5, 10, 50 or 100 mM L-NAME had no effect on the expression of any of these symptoms or their rate of compensation. By contrast, pre-UL treatment with 100 mM L-NAME resulted in a decrease in SN frequency at 10 h post-UL and an increase in its rate of compensation. Lower concentrations had no effect on SN. Pre-UL treatment with L-NAME had no significant effect on YHT or RHT at any particular time point. Analysis of NOS activity demonstrated that the highest concentration of L-NAME inhibited NOS activity in the contralateral vestibular nucleus complex, bilateral cerebellum and bilateral cortices. These results suggest that L-NAME may have different effects on vestibular compensation in guinea pigs compared to other species, such as the rat and frog.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11677743     DOI: 10.1080/000164801750388126

Source DB:  PubMed          Journal:  Acta Otolaryngol Suppl        ISSN: 0365-5237


  3 in total

1.  Metabotropic glutamate receptors as targets of neuromodulatory influence of nitric oxide.

Authors:  I V Ryzhova; A D Nozdrachev; T V Tobias; I V Orlov; V N Chikhman; S D Solnushkin
Journal:  Dokl Biol Sci       Date:  2016-09-07

2.  Neuropharmacology of vestibular system disorders.

Authors:  Enrique Soto; Rosario Vega
Journal:  Curr Neuropharmacol       Date:  2010-03       Impact factor: 7.363

3.  Soluble Guanylate Cyclase As the Key Enzyme in the Modulating Effect of NO on Metabotropic Glutamate Receptors.

Authors:  I V Ryzhova; A D Nozdrachev; T V Tobias; E A Vershinina
Journal:  Acta Naturae       Date:  2018 Apr-Jun       Impact factor: 1.845

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.